Search clinical trials for: 5HT3

Total 13 results

Stanford University
National Institute on Drug Abuse (NIDA)

Completed

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

Opioid Withdrawal | Physical Dependence

United States
US Department of Veterans Affairs

Completed

5HT3 Antagonism and Auditory Gating in Schizophrenia

Schizophrenia

United States
Lawrence Einhorn
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Completed

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Chemotherapy-Induced Nausea and Vomiting

United States
Hoosier Cancer Research Network
Merck Sharp & Dohme LLC

Completed

Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors

Germ Cell Tumors

United States
Blokhin's Russian Cancer Research Center
RUSSCO/RakFond

Unknown

Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis (OlaCINV)

Chemotherapy-induced Nausea and Vomiting | Nausea | Vomiting | Emesis | Nausea Post Chemotherapy

Russian Federation

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe